Abstract
Actinic keratoses (AKs) are evolving, malignant cutaneous neoplasms. AKs can be treated with physical or destructive methods and with topical therapies. This article is the first in a 2-part series that will review current topical therapeutic options for AKs. Several topical treatment options offer some significant benefit for the alleviation of these lesions. Therapies include 5-fluorouracil, imiquimod, diclofenac, colchicine, and retinoids. The first part of this review will focus on topical 5-fluorouracil and imiquimod.
MeSH terms
-
Administration, Cutaneous
-
Aminoquinolines / administration & dosage
-
Aminoquinolines / therapeutic use*
-
Antimetabolites, Antineoplastic / administration & dosage
-
Antimetabolites, Antineoplastic / therapeutic use*
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / therapeutic use*
-
Fluorouracil / administration & dosage
-
Fluorouracil / therapeutic use*
-
Humans
-
Imiquimod
-
Keratosis / drug therapy*
-
Keratosis / pathology
-
Precancerous Conditions / drug therapy
-
Precancerous Conditions / pathology
-
Randomized Controlled Trials as Topic
-
Skin Neoplasms / drug therapy
-
Skin Neoplasms / pathology
Substances
-
Aminoquinolines
-
Antimetabolites, Antineoplastic
-
Antineoplastic Agents
-
Imiquimod
-
Fluorouracil